Exhibit 99.1

                                  CERTIFICATION
                       PURSUANT TO 18 U.S.C. SECTION 1350,
           AS ADOPTED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

           I, Samuel Rubinstein, as General Manager and Senior Vice President of
Taro Pharmaceutical Industries Ltd. (the "Company") certify, pursuant to 18
U.S.C.ss. 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002,
that to my knowledge:

           (1) the accompanying Form 20-F report for the period ending December
31, 2002 as filed with the U.S. Securities and Exchange Commission (the
"Report") fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and

           (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.



                                                     By: /s/ Samuel Rubinstein
                                                        ------------------------
                                                         Samuel Rubinstein
Date:  April  30, 2003                                   Senior Vice President